Hard to Treat Diseases (HTDS)

[Dragonwing]

Vaxines Trading Inc

Vaxines Trading is a 100% Filipino-owned pharmaceutical company founded in 1997 aiming to support the government and the medical community in its campaign to eradicate certain diseases through vaccination.

VTI played a major role in the sub-distribution of the products of multinational companies here in the Philippines such as Merck Sharp and Dohme, Chiron (Marketlink), Aventis Pasteur, Glaxo-Smithkline, Berna and Organon until they finally became an importer of their own product in August 2003 of which is known as TEMREVAC-HB, a recombinant hepatitis B vaccine from Beijing, China. As of today, about half a million doses of Temrevac-HB has been distributed all over the Philippines. VTI have successfully registered two (2) more products, Diphtheria, Tetanus and Acellular Pertusis vaccine (DTaP) with a brand name of Tripavac, and now, the only single dose hepatitis A vaccine available in the market today, Mevac-A.

Thriving on worthy partnerships, The Company continues to expand its operations reaching more and more areas in the country by appointing partners located strategically in the different provinces of Luzon, Visayas and Mindanao. Adding more partners who are able and equipped with the same mission-vision is one of the plans of the company to enable it to become the largest National Company specializing in the distribution of vaccines nationwide, firmly adhering to its commitment to provide the most affordable and yet high quality products for the Filipino people.

For twelve (12) years, VTI have maintained good relation with all its suppliers namely; Zuellig Pharma Corp., Two World Traders, Zylan Pharma, Marketlink International, Reymed Enterprise and abroad, Beijing Tiantan Biological Products Co. Ltd., and Shenzhen Mellow Hope Industrial Pharm. Appointed as a new partner of Solvay and Novartis., Vaxines Trading Inc, have truly established itself as a worthy partner.

http://vaxinesinc.com/profile.html